Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Manhattan Associates Inc (MANH) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance

Manhattan Associates IncTrade
Relay Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Manhattan Associates Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? Manhattan Associates Inc trades at $206.18 (market cap $11.79B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: Manhattan Associates Inc is far larger — about 3× Relay Therapeutics Inc. Common Stock's market cap, and Manhattan Associates Inc is more actively traded (393,599 versus 3,432,928). Which is the better fit depends on your goals — on Pluang, investors hold Manhattan Associates Inc for 12 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.

MANHRLAY
Market Cap
$11.79B$3.94B
Volume
393,5993,432,928
Sector
TechnologyHealth
52-Week High
$223.76$20.75
52-Week Low
$120.88$6.03
Typical Hold Time
12 Days0 Days
Enterprise Value
$11.66B$3.06B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Manhattan Associates Inc

MANH trades at $202.11, down 0.36% on the day, with a bearish technical signal and key support at $201. The company shows strong profitability with a net income margin of 18.67% and has beaten earnings estimates for the last three quarters. Recent news includes a law firm investigation into fiduciary duties and a product launch of Editions for its supply chain solutions.

The outlook is mixed: strong fundamentals and analyst buy ratings support upside to the $210.50 consensus target, but technical weakness and the ongoing legal investigation pose near-term risks. Earnings growth remains the key catalyst for further price appreciation.

Relay Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MANH

No sentiment data available yet.

RLAY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Manhattan Associates Inc

Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.

Read more on MANH →

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →